(2011). Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer. BMC Cancer, 11(1), 496. https://doi.org/10.1186/1471-2407-11-496
Chicago Style (17th ed.) Citation"Pharmacogenetic Profiling and Cetuximab Outcome in Patients with Advanced Colorectal Cancer." BMC Cancer 11, no. 1 (2011): 496. https://doi.org/10.1186/1471-2407-11-496.
MLA (9th ed.) Citation"Pharmacogenetic Profiling and Cetuximab Outcome in Patients with Advanced Colorectal Cancer." BMC Cancer, vol. 11, no. 1, 2011, p. 496, https://doi.org/10.1186/1471-2407-11-496.
Warning: These citations may not always be 100% accurate.
